
Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release.

Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release.
SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library SHOW MORE
ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery. SHOW MORE
Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. SHOW MORE
October 6, 2021 Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic...
Published: September, 2019 A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced by glatiramer...
Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

+52 (55) 5729 6000 Ext. 62543
Escuela Nacional de Ciencias Biológicas. Prolongación de Carpio y Plan de Ayala S/N, Del. Miguel Hidalgo, CDMX, C.P. 11340.
©2026 UDIBI